NYU Langone Health

NYU Langone Health is a world-class integrated academic health system and one of the largest in the Northeast—stretching across 7 inpatient facilities and over 320 locations throughout the New York City region and in Florida. Guided by our purpose, City region and in Florida. Guided by our purpose, to deliver the best outcomes in patient care, education, and science, our more than 53,000 staff members provide life-changing care, innovative medical education, and groundbreaking advances in research. Our mission to care, to teach, to discover is achieved daily through a culture of exceptionalism. Our values of performance, respect, integrity, diversity, and excellence (PRIDE) influence the way we show up each and every day for our patients, our students, and our communities. In 2024, NYU Langone Health’s revenue was $14.2 billion, including more than $5 billion in philanthropy since 2007. NYU Langone has been ranked the No. 1 comprehensive academic medical center for quality care in the United States for three years in a row by Vizient Inc., the nation’s largest healthcare performance improvement organization. Our hospitals in Manhattan and Brooklyn and on Long Island have received straight A’s for safety from The Leapfrog Group, a national nonprofit organization that monitors healthcare safety and quality. Only 4 percent of graded hospitals nationwide have earned 10 consecutive “A” ratings, underscoring our commitment to keeping patients safe and providing the best outcomes. Because of our commitment to continuous improvement and delivering safe, high-quality care, we have received The Gold Seal of Approval® by The Joint Commission. We are among the best hospitals in the U.S. according to U.S. News and World Report’s 2024–25 “Best Hospitals Honor Roll,” earning top 20 rankings in 13 specialties, 11 of which are in the top 10. Rusk Rehabilitation is consistently ranked the No. 1 rehabilitation program in New York State and one of the top five in the country by U.S. News & World Report. The Centers for Medicare and Medicaid Services has awarded NYU Langone a five-star rating for quality. We are the only health system—that is, a multispecialty and multisite hospital organization—in New York to receive Magnet® Recognition across all our hospitals for excellence in nursing and quality patient care from the American Nurses Credentialing Center, an honor achieved by only 9.8 percent of hospitals in the United States. NYU Langone was founded as the Medical College of New York University in 1841 by Valentine Mott, MD, the premier surgeon of his day, and five other eminent physicians and scientists. NYU Langone’s first hospital, known as University Hospital, was established in 1948, a century after its Medical College. In 1963, a newly acquired site in midtown Manhattan became the home of University Hospital’s new 18-story building. Adopting a novel concept in healthcare, the more than 350-bed acute-care facility—now Tisch Hospital—partnered with outpatient practices to speed the translation of scientific discovery to the clinic and allow physicians to conduct academic and research activities while maintaining private practice. The first hospital to merge with our institution was the Hospital for Joint Diseases, now known as NYU Langone Orthopedic Hospital. The 225-bed hospital, a longtime affiliate, became NYU Langone’s dedicated orthopedic hospital in 2006. In 2018, a new Science Building, NYU Langone’s largest research facility, united teams of investigators previously housed in several facilities. That same year, the Helen L. and Martin S. Kimmel Pavilion opened and became the only inpatient facility in New York City with exclusively private rooms. Of its 374 beds, 68 are in Hassenfeld Children’s Hospital at NYU Langone, the city’s first new children’s hospital in nearly 15 years. In 2016, we acquired Lutheran Medical Center, a 444-bed acute-care hospital in southwest Brooklyn. Within several years, NYU Langone Hospital—Brooklyn, as it was renamed, benefited so greatly from our health system’s infusion of resources and expertise that it now qualifies as one of the safest hospitals, not only in New York City, but also in the nation. The only five-star hospital in Brooklyn, as ranked by CMS, NYU Langone Hospital—Brooklyn is the first and only hospital in Brooklyn to receive Magnet recognition for excellence in nursing and quality patient care. In 2019, NYU Langone extended its reach once again, this time to Nassau County on Long Island. Our acquisition of Winthrop University Hospital, a 591-bed acute-care hospital in Mineola, enlarged the NYU Langone system by 25 percent. Thanks to the same rigorous quality control measures implemented at our Brooklyn hospital, NYU Langone Hospital—Long Island, as it was renamed, saw its average length of stay, a key measure of patient safety, decrease by nearly 20 percent in just two years. To further strengthen NYU Langone’s presence on Long Island, in March 2025, NYU Langone merged with Long Island Community Hospital to create NYU Langone Hospital—Suffolk. This 306-bed medical center is home to the Knapp Cardiac Care Center, an advanced facility for heart disease diagnosis and treatment, as well as a modern ambulatory surgical pavilion. It offers specialized services, including women’s imaging, a sleep laboratory, and bariatric surgery, and serves as the entry point for a Provisional Level 2 Trauma Center. The hospital is also designated by the New York State Department of Health as a Primary Stroke Center. In addition to providing our patients the best quality and safety outcomes, our clinicians and researchers have set new standards for the diagnosis and treatment of diseases and have made or contributed to breakthroughs in biomedical science. In 2015, a team of surgeons led by Eduardo D. Rodriguez, MD, DDS, Helen L. Kimmel Professor of Reconstructive Plastic Surgery and chair of NYU Langone’s Hansjörg Wyss Department of Plastic Surgery, performed the most extensive face transplant to date, followed in 2020 by the world’s first successful face and double-hand transplant, and in 2023 by the world’s first whole-eye and partial-face transplant. In 2021, a team of surgeons led by Robert Montgomery, MD, DPhil, director of the NYU Langone Transplant Institute, the H. Leon Pachter, MD, Professor of Surgery, and chair of the Department of Surgery, performed the first investigational transplant of a kidney grown in a genetically altered pig to a brain-dead person whose bodily functions were sustained by mechanical support. In separate investigational procedures performed in June and July 2022, surgeons led by Dr. Montgomery successfully transplanted hearts from genetically altered pigs into brain-dead patients, marking the latest advance toward addressing the nationwide organ shortage and developing a clinical protocol that would provide an alternative supply of organs for people with life-threatening heart disease. In 2024, Dr. Montgomery and his team of surgeons performed the world’s first combined implant of a mechanical heart pump and transplant of a kidney from a genetically modified pig, and later in the year, the first transplantation of a pig kidney with 10 gene edits. In 2024, Stephanie H. Chang, MD, associate professor in the Department of Cardiothoracic Surgery at NYU Grossman School of Medicine and the surgical director of the Lung Transplant Program at NYU Langone Transplant Institute, achieved a historic milestone by leading the nation’s first fully robotic lung transplant. Later that year, she further advanced medical innovation by heading the team that performed the world’s first double lung transplant using this robotic technology. ...view more